Meglumine is combined as an excipient (an inert substance) not an active ingredient.

Appearance:White crystalline powder;Assay: 99% min.; Specific rotation [α]25D:-15.7 o~17.3 o;Loss on drying: <1%It is commonly used as contrast agent, excipient and resolving agent during sythesis of APIs.

Meglumine is combined as an excipient (an inert substance) not an active ingredient. 1.Excipients are added to ensure that the shelf-life of the active ingredients can be long enough to be active until internal use. 2.Excipients are combined also to support the active ingredients, so that the latter can be easily administered or absorbed in the body. 3.Examples of meglumine-combined drugs are flunixin meglumine (non-steroidal anti-inflammatory drugs, used as a veterinary anti-inflammatory and analgesic) and meglumine antimoniate (antiprotozoal to treat leishmaniasis). 4.Meglumine is used in ion-exchange resins to chelate boron ions selectively. N-alkyl glucamines are used in preparing functional surfactants and some solutions which are stable over a wide range of pH and ionic strength..

meglumine